Literature DB >> 2109543

Is it cost-beneficial to screen adolescent males for chlamydia?

E R Alexander.   

Abstract

Mesh:

Year:  1990        PMID: 2109543      PMCID: PMC1404650          DOI: 10.2105/ajph.80.5.531

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  7 in total

1.  Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.

Authors:  A G Randolph; A E Washington
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

2.  Cost-effectiveness of culturing for Chlamydia trachomatis. A study in a clinic for sexually transmitted diseases.

Authors:  M D Nettleman; R B Jones; S D Roberts; B P Katz; A E Washington; R S Dittus; T S Quinn
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

3.  The economic cost of pelvic inflammatory disease.

Authors:  A E Washington; P S Arno; M A Brooks
Journal:  JAMA       Date:  1986-04-04       Impact factor: 56.272

4.  Sounding board. Decision Analysis: a look at the chief complaints.

Authors:  W B Schwartz
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

5.  Hidden ethical issues in clinical decision analysis.

Authors:  A S Brett
Journal:  N Engl J Med       Date:  1981-11-05       Impact factor: 91.245

6.  Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males.

Authors:  M A Shafer; J Schachter; A B Moscicki; A Weiss; J Shalwitz; E Vaughan; S G Millstein
Journal:  JAMA       Date:  1989-11-10       Impact factor: 56.272

7.  Use of a leukocyte esterase dipstick to detect Chlamydia trachomatis and Neisseria gonorrhoeae urethritis in asymptomatic adolescent male detainees.

Authors:  S F O'Brien; T A Bell; J A Farrow
Journal:  Am J Public Health       Date:  1988-12       Impact factor: 9.308

  7 in total
  1 in total

Review 1.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.